BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei S, Paskeh MDA, Saghari Y, Zarrabi A, Hamblin MR, Entezari M, Hashemi M, Aref AR, Hushmandi K, Kumar AP, Rabiee N, Ashrafizadeh M, Samarghandian S. Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator? Int J Biol Macromol 2022:S0141-8130(22)00340-3. [PMID: 35202639 DOI: 10.1016/j.ijbiomac.2022.02.094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomedicine & Pharmacotherapy 2023;158:114168. [DOI: 10.1016/j.biopha.2022.114168] [Reference Citation Analysis]
2 Lu MK, Jen CI, Chao CH, Hsu YC, Ng LT. SPS, a sulfated galactoglucan of Laetiporus sulphureus, exhibited anti-inflammatory activities. Int J Biol Macromol 2023;226:1236-47. [PMID: 36442562 DOI: 10.1016/j.ijbiomac.2022.11.237] [Reference Citation Analysis]
3 Feng J, Li Y, He F, Zhang F. RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer. Environ Toxicol 2023. [PMID: 36715115 DOI: 10.1002/tox.23741] [Reference Citation Analysis]
4 Owen JS, Clayton A, Pearson HB. Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer. Biomolecules 2022;13. [PMID: 36671452 DOI: 10.3390/biom13010067] [Reference Citation Analysis]
5 Dai Z, Huang Q, Huang X, Zhu C, Zahid KR, Liu T, Li Q, Wu C, Peng M, Xiao X, Raza U, Yu N, Zeng T. KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma. Molecular Carcinogenesis 2022. [DOI: 10.1002/mc.23492] [Reference Citation Analysis]
6 Shree B, Das K, Sharma V. The emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis. Cancer Pathogenesis and Therapy 2022. [DOI: 10.1016/j.cpt.2022.12.003] [Reference Citation Analysis]
7 Wang P, Yan Z, Zhou PK, Gu Y. The Promising Therapeutic Approaches for Radiation-Induced Pulmonary Fibrosis: Targeting Radiation-Induced Mesenchymal Transition of Alveolar Type II Epithelial Cells. Int J Mol Sci 2022;23. [PMID: 36499337 DOI: 10.3390/ijms232315014] [Reference Citation Analysis]
8 Hashemi M, Taheriazam A, Daneii P, Hassanpour A, kakavand A, Rezaei S, Hejazi ES, Aboutalebi M, Gholamrezaie H, Saebfar H, Salimimoghadam S, Mirzaei S, Entezari M, Samarghandian S. Targeting PI3K/Akt signaling in prostate cancer therapy. J Cell Commun Signal 2022. [DOI: 10.1007/s12079-022-00702-1] [Reference Citation Analysis]
9 Pellegrino M, Ricci E, Ceraldi R, Nigro A, Bonofiglio D, Lanzino M, Morelli C. From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer. Cancers (Basel) 2022;14:4401. [PMID: 36139561 DOI: 10.3390/cancers14184401] [Reference Citation Analysis]
10 Shi X, Niu Y, Yang Y, Wang N, Yuan M, Yang C, Dong A, Zhu H, Jia X, Xu Q. Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/1727575] [Reference Citation Analysis]
11 Chandran E, Meininger L, Karzai F, Madan RA. Signaling new therapeutic opportunities: cytokines in prostate cancer. Expert Opin Biol Ther 2022. [PMID: 35930001 DOI: 10.1080/14712598.2022.2108701] [Reference Citation Analysis]
12 Li L, Yu J, Cheng S, Peng Z, Ben-David Y, Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int J Biol Macromol 2022;209:1155-68. [PMID: 35447268 DOI: 10.1016/j.ijbiomac.2022.04.076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Maria Teresa Palano, Matteo Gallazzi, Martina Cucchiara, Federico Dehò, Paolo Capogrosso, Antonino Bruno, Lorenzo Mortara. The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors. Explor Target Antitumor Ther 2022;3. [PMID: 36338516 DOI: 10.37349/etat.2022.00108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]